KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancerYanhong Deng, Jianping Wang, Ruoxu Dou et al.|Molecular Oncology|2015Cited by 60
Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancerRuoxu Dou, Jianping Wang, Yanhong Deng et al.|Cancer Letters|2013Cited by 19